Evidence map›Paper›PMID 32626787›Full record

ArticleJournal of immunology research2020

Hippocampal Atrophy in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations.

Shuang Liu, Yuqi Cheng, Yueyin Zhao, Aiyun Lai, Zhaoping Lv, Zhongqi Xie, Bibhuti Upreti, Xiangyu Wang, Xiufeng Xu, Chunrong Luo and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Shuang LiuDepartment of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.ORCID https://orcid.org/0000-0002-7961-910X
Yuqi ChengYunnan Key Laboratory of Laboratory Medicine, Kunming 650032, China.
Yueyin ZhaoDepartment of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
Aiyun LaiDepartment of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
Zhaoping LvDepartment of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
Zhongqi XieDepartment of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
Bibhuti UpretiDepartment of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
Xiangyu WangDepartment of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
Xiufeng XuDepartment of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
Chunrong LuoMagnetic Resonance Imaging Center, The First Hospital of Kunming, Kunming 650011, China.
Hongjun YuMagnetic Resonance Imaging Center, The First Hospital of Kunming, Kunming 650011, China.
Baoci ShanKey Laboratory of Nuclear Analysis, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China.
Lin XuKey Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China.ORCID https://orcid.org/0000-0002-2710-3507
Jian XuDepartment of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.ORCID https://orcid.org/0000-0003-1612-561X
Kunming Medical University · CNThe First Hospital of Kunming · CNChinese Academy of Sciences · CNKunming Institute of Zoology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was conducted to explore hippocampal structural changes and their possible associations with clinical characteristics, emotional status, and treatment regimens in patients with systemic lupus erythematosus (SLE) without major neuropsychiatric manifestations (non-NPSLE). Eighty-five non-NPSLE patients with normal conventional magnetic resonance imaging (MRI) and seventy-seven matched healthy control (HC) subjects were recruited. All participants underwent the standard high-resolution volumetric MRI. The bilateral hippocampal volume (HIPV) and hippocampal density (HIPD) were calculated, respectively, for each participant. We found that the bilateral HIPV and HIPD of the SLE patient group were significantly less than those of the HC group. The bilateral HIPV of female patients were significantly less than those of male patients. The SLE disease activity index (SLEDAI) was negatively correlated with the bilateral HIPV and the right HIPD. Urine protein quantity was negatively correlated with the bilateral HIPV and HIPD. Hydroxychloroquine (HCQ) showed a protective effect on right HIPV. In conclusion, we found that the early hippocampal atrophy could occur before obvious neuropsychiatric manifestations and might be associated with SLE disease activity and organ damages. Early detection and intervention of hippocampal damage might prevent the progression to NPSLE. More studies are needed to fully understand the underlying mechanisms of hippocampal atrophy in SLE.

Indexed as

AdultAtrophyAutoantibodiesCase-Control StudiesFemaleHippocampusHumansImage Processing, Computer-AssistedLupus Erythematosus, SystemicMagnetic Resonance ImagingMaleMental DisordersMiddle AgedNervous System DiseasesSymptom AssessmentYoung AdultAutoantibodies

Identifiers

PMID32626787
PMCPMC7306071
OpenAlexW3035063484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.